TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 17:09:37 GMT 2025` Edited by `admin` on `Tue Apr 01 17:09:37 GMT 2025`
Protein Type	RECEPTOR
Protein Sub Type	TNF RECEPTOR
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	PK6VHJAIBD
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 17

Common Name

English

B-CELL MATURATION PROTEIN

Preferred Name

English

CD-269

Common Name

English

CD269

Common Name

English

BCMA

Common Name

English

TNFRSF17

Common Name

English

Code System Code Type Description

UNIPROT

Q02223

Created by admin on Tue Apr 01 17:09:37 GMT 2025 , Edited by admin on Tue Apr 01 17:09:37 GMT 2025

PRIMARY

FDA UNII

PK6VHJAIBD

Created by admin on Tue Apr 01 17:09:37 GMT 2025 , Edited by admin on Tue Apr 01 17:09:37 GMT 2025

PRIMARY

From	To
1_8	1_21
1_24	1_37
1_28	1_41

Related Record Type Details


					L97FGF546Q

LIGAND->TARGET

Amount:


					8PX1X7UG4D

IDECABTAGENE VICLEUCEL

CYTOTOXIC T-CELL->TARGET

Amount:


					GMV2GFP3G2

ZEVORCABTAGENE AUTOLEUCEL

CYTOTOXIC T-CELL->TARGET

Amount:


					WQD5K35YZT

Anitocabtagene Autoleucel

CYTOTOXIC T-CELL->TARGET

Amount:


					7CH7MR6SN5

MOTACABTAGENE LUREVGEDLEUCEL

CYTOTOXIC T-CELL->TARGET

Amount:


					7OSV6M6T4D

LIGAND->TARGET

Amount:


					DCY3M5W6TC

Cesnicabtagene Autoleucel

CYTOTOXIC T-CELL->TARGET

Amount:


					P5TLS56PWW

Cizutamig

LIGAND->TARGET

Interaction Type:

PRECLINICAL

Amount:


					VT894H6T3S

LIGAND->TARGET

Amount:


					CZ3K2AB2XK

Pamlectabart Tismanitin

LIGAND->TARGET

Interaction Type:

IN-VITRO

Amount:


					YQ4C0NDW44

MEDI-2228

LIGAND->TARGET

Amount:


					30WLL6DR9O

LIGAND->TARGET

Amount:


					GLR3JG8TZU

LIGAND->TARGET

Amount:


					L0HR9A577V

ANTIGEN->TARGET

Amount:


					54534MX6Z9

INHIBITOR -> TARGET

Interaction Type:

BINDING

Amount:


					Q137JC2CLV

Nendocabtagene Onogedleucel

CYTOTOXIC T-CELL->TARGET

Interaction Type:

IN-VITRO

Amount:


					R2U3SU5R9H

Trovocabtagene Autoleucel

CYTOTOXIC T-CELL->TARGET

Amount:


					XMS5Q5W5V7

LIGAND->TARGET

Interaction Type:

IN-VITRO

Amount:


					YTJ3XRJ4ZN

Equecabtagene Autoleucel

CYTOTOXIC T-CELL->TARGET


					H9BE3VZU4A

Ribrecabtagene Autoleucel

INHIBITOR -> TARGET

Amount:


					K8RW1TW3EM

ORVACABTAGENE AUTOLEUCEL

INHIBITOR -> TARGET


					102VUR9WQE

LIGAND->TARGET

Amount:


					DB1041CXDG

BELANTAMAB MAFODOTIN

CONJUGATED TOXIN->TARGET

Amount:


					WM18Z62RTI

INHIBITOR -> TARGET

Comments:

Blocking potency of BCMA binding to APRIL

Interaction Type:

BINDING

Qualification:

IC50

Amount:


					Y69B45U0TK

AMG-224

CONJUGATED TOXIN->TARGET


					D6ZL787LZ9

Durcabtagene Autoleucel

CYTOTOXIC T-CELL->TARGET

Amount:


					CO86AOP337

Etentamig

LIGAND->TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL